Skip to main content

Closing Bell: Cipher Pharmaceuticals Inc up on Wednesday (CPH)

Automated Summaries - The Globe and Mail - Wed Jul 17, 4:01PM CDT

In trading today, Cipher Pharmaceuticals Inc opened at $8.31 and closed at $8.33. prices ranged from $8.25 to $8.45.

The price raised 0.24% from the previous day's close of $8.31.

During the day across North America, the TSX Composite closed 1.07% at 22995.39, the S&P 500 closed 0.64% at 5667.20, the Dow Jones Industrial Average closed 1.85% at 40954.48 and the Nasdaq Composite closed 0.20% at 18509.34.

Cipher Pharmaceuticals Inc traded under CPH on the Toronto Stock Exchange (TSX).

A total of 22,356 shares was traded during the last trading day, with total trades of 94. On average, Cipher Pharmaceuticals Inc has traded 20,057 shares over 5 days and 32,270 year-to-date.

Trading across the entire TSX saw 2,100 price advancers against 3,108 declines and 117 unchanged.

During the prior 52 weeks, CPH.TO has traded as high as $10.33 (May 10,2024) and low as $3.35 (August 08,2023). Moreover, in the last 52 weeks, Cipher Pharmaceuticals Inc's shares have risen 134.65%, while they have boosted 50.36% since the start of 2024.

Following today's trading, Cipher Pharmaceuticals Inc has a market capitalization of $200.38 million on a float of 24,113 shares outstanding. Its annual EPS is $0.90.

Cipher Pharmaceuticals Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Currently, Cipher Pharmaceuticals Inc's consensus rating is "Moderate Buy" based on 2 analysts according to Zacks. Currently, there are 1 buy ratings and 1 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..